West Pharmaceutical Services Inc
NYSE:WST
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
276.9749
412.5043
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Accounts Receivables
West Pharmaceutical Services Inc
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Accounts Receivables
$524.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Accounts Receivables
$9.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
17%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Accounts Receivables
$3.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Accounts Receivables
$637.2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Accounts Receivables
$1.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Accounts Receivables
$3.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
12%
|
|
West Pharmaceutical Services Inc
Glance View
West Pharmaceutical Services Inc. is a leading global manufacturer of advanced drug delivery systems and medical device components, catering primarily to the pharmaceutical and biotechnology sectors. Founded in 1923, the company has built a robust reputation for its innovative solutions that enhance the safety and efficacy of medications. With a focus on producing high-quality packaging and delivery systems, West’s product lineup includes prefillable syringes, stoppers, and highly specialized devices that contribute to the growing demand for biologics and complex medications. This focus on quality has positioned West as a trusted partner for major pharmaceutical companies, and its strategic global footprint allows it to meet the rising demands of health systems worldwide. As the healthcare landscape evolves, West Pharmaceutical Services stands to benefit from several key industry trends, including the increased emphasis on patient-centric therapies and the demand for reliable and efficient drug administration methods. Investors can find assurance in the company’s commitment to innovation, as it invests heavily in research and development to stay ahead of emerging trends and regulatory changes. Additionally, West’s consistent financial performance, with steady revenue growth and healthy profit margins, showcases its resilience and operational efficiency. As the biopharmaceutical market continues to expand, West’s strategic alignment with cutting-edge therapeutic developments positions it well for future growth, painting a promising picture for potential investors looking to tap into the burgeoning healthcare sector.
See Also
What is West Pharmaceutical Services Inc's Accounts Receivables?
Accounts Receivables
524.3m
USD
Based on the financial report for Sep 30, 2024, West Pharmaceutical Services Inc's Accounts Receivables amounts to 524.3m USD.
What is West Pharmaceutical Services Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
10%
Over the last year, the Accounts Receivables growth was 1%. The average annual Accounts Receivables growth rates for West Pharmaceutical Services Inc have been 3% over the past three years , 11% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
